693 related articles for article (PubMed ID: 24837513)
1. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
[TBL] [Abstract][Full Text] [Related]
2. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
3. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.
Selvapandiyan A; Dey R; Nylen S; Duncan R; Sacks D; Nakhasi HL
J Immunol; 2009 Aug; 183(3):1813-20. PubMed ID: 19592661
[TBL] [Abstract][Full Text] [Related]
4. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
[TBL] [Abstract][Full Text] [Related]
5. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
[TBL] [Abstract][Full Text] [Related]
6. Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
Fiuza JA; Dey R; Davenport D; Abdeladhim M; Meneses C; Oliveira F; Kamhawi S; Valenzuela JG; Gannavaram S; Nakhasi HL
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004322. PubMed ID: 26752686
[TBL] [Abstract][Full Text] [Related]
7. Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis.
Pandey SC; Kumar A; Samant M
Parasite Immunol; 2020 Sep; 42(9):e12732. PubMed ID: 32418227
[TBL] [Abstract][Full Text] [Related]
8. New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent
Almeida APMM; Machado LFM; Doro D; Nascimento FC; Damasceno L; Gazzinelli RT; Fernandes AP; Junqueira C
Front Immunol; 2018; 9():465. PubMed ID: 29599776
[TBL] [Abstract][Full Text] [Related]
9. DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis.
Pandey SC; Pande V; Samant M
Sci Rep; 2020 Oct; 10(1):18218. PubMed ID: 33106577
[TBL] [Abstract][Full Text] [Related]
10. Live Attenuated
Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
[TBL] [Abstract][Full Text] [Related]
11. Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.
Fernandes AP; Coelho EA; Machado-Coelho GL; Grimaldi G; Gazzinelli RT
Curr Opin Microbiol; 2012 Aug; 15(4):476-85. PubMed ID: 22698479
[TBL] [Abstract][Full Text] [Related]
12. Leishmanization revisited: immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis.
McCall LI; Zhang WW; Ranasinghe S; Matlashewski G
Vaccine; 2013 Feb; 31(10):1420-5. PubMed ID: 23219435
[TBL] [Abstract][Full Text] [Related]
13. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
[TBL] [Abstract][Full Text] [Related]
14. Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis.
Karmakar S; Ismail N; Oliveira F; Oristian J; Zhang WW; Kaviraj S; Singh KP; Mondal A; Das S; Pandey K; Bhattacharya P; Volpedo G; Gannavaram S; Satoskar M; Satoskar S; Sastry RM; Oljuskin T; Sepahpour T; Meneses C; Hamano S; Das P; Matlashewski G; Singh S; Kamhawi S; Dey R; Valenzuela JG; Satoskar A; Nakhasi HL
Commun Biol; 2021 Jul; 4(1):929. PubMed ID: 34330999
[TBL] [Abstract][Full Text] [Related]
15. Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs.
Avishek K; Kaushal H; Gannavaram S; Dey R; Selvapandiyan A; Ramesh V; Negi NS; Dubey US; Nakhasi HL; Salotra P
Sci Rep; 2016 Sep; 6():33059. PubMed ID: 27624408
[TBL] [Abstract][Full Text] [Related]
16. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
17. Identification of protein biomarkers of attenuation and immunogenicity of centrin or p27 gene deleted live vaccine candidates of Leishmania against visceral leishmaniasis.
Tandon R; Reyaz E; Roshanara ; Jadhav M; Gandhi M; Dey R; Salotra P; Nakhasi HL; Selvapandiyan A
Parasitol Int; 2023 Feb; 92():102661. PubMed ID: 36049661
[TBL] [Abstract][Full Text] [Related]
18. Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.
Anand S; Madhubala R
Sci Rep; 2015 Jun; 5():10706. PubMed ID: 26035062
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
20. Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.
Dey R; Dagur PK; Selvapandiyan A; McCoy JP; Salotra P; Duncan R; Nakhasi HL
J Immunol; 2013 Mar; 190(5):2138-49. PubMed ID: 23338240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
